Viewing Study NCT03021369


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-01-04 @ 3:47 PM
Study NCT ID: NCT03021369
Status: COMPLETED
Last Update Posted: 2020-02-25
First Post: 2017-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Two Different Pleural Drainage Systems
Sponsor: Kerckhoff Klinik
Organization:

Study Overview

Official Title: Vergleich Zweier Thoraxdrainage-Systeme in Der Herzchirurgie
Status: COMPLETED
Status Verified Date: 2020-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The digital pleural drainage system Topaz+ by Medela is compared to the analogue system Atrium OCEAN by Maquet in patients undergoing cardiac surgery.

The study is prospectively randomized with an all-comer setup. The patients are randomly selected for one of the systems. The surgery is performed in the standard fashion and chest tubes are placed routinely by the surgeon depending on the type of surgery. A retrosternal 32 French drain is placed in every patient and pericardial and/or pleural drains are optional.

The postoperative course does not vary from the clinical standard and the chest tubes are removed according to institutional standard. The clinical data about fluid amount, time of removal, air leaks, tamponade are routinely collected in a digital patient documentation system.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: